FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/029548 [Registered on: 03/12/2020] Trial Registered Prospectively
Last Modified On: 21/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Ayurvedic management of Psoriasis.  
Scientific Title of Study   A comparative study of Lelitaka-Makshika Yoga processed with Amalaki Svarasa and Lelitaka-Makshika Yoga processed with Jatipatra Svarasa in the management of Psoriasis. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Palak S Singhal  
Designation  PG Scholar  
Affiliation  J S Ayurveda Mahavidyalaya  
Address  Department of Kayachikitsa, J S Ayurveda Mahavidyalaya, College Road, Nadiad.
Department of Kayachikitsa, J S Ayurveda Mahavidyalaya, College Road, Nadiad.
Kheda
GUJARAT
387001
India 
Phone  9727716549  
Fax    
Email  palaksinghal96@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dhaval Dholakiya 
Designation  Reader 
Affiliation  J S Ayurveda Mahavidyalaya  
Address  Department of Kayachikitsa, J S Ayurveda Mahavidyalaya, College Road, Nadiad
Department of Kayachikitsa, J S Ayurveda Mahavidyalaya, College Road, Nadiad
Kheda
GUJARAT
387001
India 
Phone  7016786089  
Fax    
Email  vddhavaldholakiya1910@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Dhaval Dholakiya 
Designation  Reader 
Affiliation  J S Ayurveda Mahavidyalaya  
Address  Department of Kayachikitsa, J S Ayurveda Mahavidyalaya, College Road, Nadiad.
Department of Kayachikitsa, J S Ayurveda Mahavidyalaya, College Road, Nadiad.
Kheda
GUJARAT
387001
India 
Phone  7016786089  
Fax    
Email  vddhavaldholakiya1910@gmail.com  
 
Source of Monetary or Material Support  
P.D.Patel Ayurveda Hospital, J.S. Ayurveda Mahavidyalaya Campus, College road Nadiad. 
 
Primary Sponsor  
Name  J S Ayurveda Mahavidyalaya  
Address  J S Ayurveda Mahavidyalaya, College road, Nadiad 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Palak Singhal   P D Patel Ayurveda Hospital   Department of Kayachikitsa, P D Patel Ayurveda Hospital, J S Ayurveda Mahavidyalaya, College Road, Nadiad.
Kheda
GUJARAT 
9727716549

palaksinghal96@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE FOR HUMAN RESEARCH   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L409||Psoriasis, unspecified. Ayurveda Condition: PSORIASIS,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1 Lelitaka-Makshika Yoga processed with Amalaki Svarasa 2 Lelitaka-Makshika Yoga processed with Jatipatra Svarasa  1 Lelitaka-Makshika Yoga processed with Amalaki Svarasa-2 tablets twice daily after meal 2 Lelitaka-Makshika Yoga processed with Jatipatra Svarasa- 2 tablets twice daily after meal 
Comparator Agent  NOT APPLICABLE  NOT APPLICABLE 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients who fulfill any three of the symptoms and any one of the signs mentioned in the diagnostic criteria.
2.Patients of age between 18 to 60 years and of both the gender.
Diagnostic criteria
Any three of the following Symptoms:
1. Scaling (Dalana)
2. Itching (Kandu)
3. Discoloration (Krsna Aruna Varna/ Abhrakapatrasama)
4. Loss of perspiration (Asvedanam)
5. Dryness (Rukshata)
6. Erythema
7. Lesions Distribution
Anyone of the following Signs:
8. Auspitz’s sign
9. Candle grease sign
10. Koebner’s phenomena

 
 
ExclusionCriteria 
Details  1.Pregnant or lactating females
2.Patients who have taken medicine of corticosteroid drugs or immunosuppressants or other biological medicines within the last 6 months.
3.Patient with an associated disease like Hyper or Hypothyroidism, Diabetes mellitus,
Cardiovascular disorders, Liver disorder, Kidney disorders, Cancer.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes in signs and symptoms of psoriasis.  BASELINE AND AFTER 8 WEEKS. 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/12/2020 
Date of Study Completion (India) 11/01/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 11/01/2022 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
NOT APPLICABLE. THIS THESIS WORK IS YET TO BE SUBMITTED. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
 The main aim of the study is clinical evaluation of ayurvedic management in psoriasis by Lelitaka-Makshika Yoga processed with Amalaki Svarasa and Lelitaka-Makshika Yoga processed with Jatipatra Svarasa. Patients will be selected from P. D. Patel Ayurvedic Hospital, Nadiad after the conformation of the patients of psoriasis with the help of its classical signs and symptoms.
They will be treated with the following therapy 1. Lelitaka-Makshika Yoga processed with Amalaki Svarasa- 2 tablets twice daily after meal. 2.Lelitaka-Makshika Yoga processed with Jatipatra Svarasa-2 tablets twice daily after meal. 
Psoriasis is a chronic, non-communicable, recurrent, inflammatory, hyperproliferative skin disease. It is characterized by well-defined erythematous, dry plaques of various sizes covered with mica like scales. It particularly affects extensor surfaces and scalp, and usually follows a relapsing and remitting course. Psoriasis affects approximately 2.0% to 3.0% of the world’s population. Higher prevalence rates were found in western countries.The prevalence of Psoriasis in India is estimated to be between 0.44% and 2.8%.

Result: For all the signs and symptoms in the research work, the p-value is more than 0.05. Hence, acceptance of the tested null hypothesis is confirmed the and alternate hypothesis was rejected. In a two-sample unpaired t-test, comparing the effect of therapy, no significant difference in effect was found between the groups.  


 
Close